AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04579497 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 38-42°C rising temperature footbath
Description: A ten-minute pre-intervention rest period followed by a 30-minute footbath with 16 l of warm water. Water temperature starts at 38°C and is increased by 1°C every 6 minutes, resulting in 42°C after 30 minutes. The footbath is followed by a ten-minute post-intervention rest period.
Study NCT03180034 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed
Description: Given IM
Study NCT03180034 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT03121781 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: respiratory support- interface
Description: change interface to RAM cannula
Study NCT03121781 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: respiratory support- interface
Description: change interface to binasal prongs
Study NCT03180034 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT03180034 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Recombinant Human Papillomavirus Bivalent Vaccine
Description: Given IM
Study NCT03180034 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Recombinant Human Papillomavirus Bivalent Vaccine
Description: Given IM
Study NCT03180034 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Recombinant Human Papillomavirus Nonavalent Vaccine
Description: Given IM
Study NCT03180034 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Recombinant Human Papillomavirus Nonavalent Vaccine
Description: Given IM
Study NCT03681912 — intervention group
Intervention type: BEHAVIORAL
Intervention: Competency: 12-Item Motivational Interviewing (MI) Coach Rating Scale (CRS)
Description: Coaching feedback will be triggered by a provider falling below the competency threshold on the standardized patient interaction. Everyone will receive coaching for two assessments in the month following training. After that, if mean scores fall below competency, then the provider will receive a 45-minute coaching session by the external Motivational Interviewing Network of Trainers (MINT) facilitator.~Feedback on two highest and two lowest ratings, review of the audio recording and interactive coaching activities (e.g., fidelity assessments) targeting the lowest ratings. While many aspects of this implementation strategy are adaptable, organizational leadership will review data on completion of coaching feedback sessions and will determine corrective action for suboptimal adherence.
Study NCT03681912 — intervention group
Intervention type: BEHAVIORAL
Intervention: Randomized Guided Development of COPs with an internal facilitator after one year of implementation.
Description: Development of the CoP will be guided by scheduling and assisting in setting the agenda for the first three meetings to encourage MI practice, peer coaching and potentially fidelity monitoring, and prevent drift. In addition to CoP, half the sites will be randomized to receive an internal facilitator who will be trained to continue quarterly fidelity monitoring and coaching feedback when scores fall below competency.
Study NCT03681912 — intervention group
Intervention type: BEHAVIORAL
Intervention: CoP development without internal facilitation.
Description: Development of the CoP will be guided by scheduling and assisting in setting the agenda for the first three meetings to encourage MI practice, peer coaching and potentially fidelity
Study NCT00439907 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: End-to-end repair of the external anal sphincter muscle
Description: Surgical procedure: End-to-end repair of the external anal sphincter muscle
Study NCT00439907 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Overlap repair of the external anal sphincter muscle
Description: Surgical procedure: Overlap repair of the external anal sphincter muscle
Study NCT03327688 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Point-of-care ultrasound
Description: Point-of-care ultrasound performed by an emergency physician
Study NCT02619279 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Livelihood intervention
Description: Participants' mothers will receive a livelihood intervention package consisting of a orientation and training and a loan package of chickens and associated implements to create poultry microenterprises.
Study NCT00752856 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Kaletra + Isentress
Description: kaletra 2 tabs twice a day + Raltegravir 1 tab twice a day
Study NCT00752856 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Atripla
Description: Atripla 1 tab once a day
Study NCT01942798 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Nintendo Wii
Description: Subjects will receive the intervention for 40-minute sessions, 3x/week for 4 weeks. The interventions will be administered in combination of onsite group training and individualized home-based training.
Study NCT01942798 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Wii Big Brain Academy Degree program
Description: Subjects will receive the intervention for 40-minute sessions, 3x/week for 4 weeks. The interventions will be administered in combination of onsite group training and individualized home-based training.
Study NCT00386724 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Precision Spinal Cord Stimulation System
Description: Precision System aids in the management of chronic intractable pain of the trunk and/or limbs, including unilateral or bilateral pain associated with the following: failed back surgery syndrome, intractable back pain, and leg pain.
Study NCT00386724 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Artisan Surgical Lead
Description: Artisan paddle electrode is a 2 x 8 surgical lead approved for use as part of the Precision System.
Study NCT04044846 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical activity program for homebound older adults faciliated by Personal Support Workers
Description: The intervention is an evidence- informed, theory-driven mobility intervention for community-dwelling OAs who are moderately and severely frail according to the clinical frailty scale (Rockwood et al., 2005). The intervention, entitled Promoting Movement in OAs (ProMO), will be implementable with frail OAs in partnership with any care provider in the home. Investigators will focus the study on the two main providers of care- personal support workers (PSWs) and family caregivers. OAs, PSWs, and caregivers will co-create ProMO with us. ProMO will be distinct from existing home-based exercise programs (Johnson et al., 2003) (Giangregorio et al., 2018) because it will optimize natural opportunities for mobilization during care (e.g., bathing and dressing) and will be embedded in facilitated activities of daily living.
Study NCT01082107 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Solar disinfection in transparent containers (plastic bottles)
Description: Participants in the study drink solar disinfected (SODIS) water. Solar disinfected water is water (> 3 L) that has been placed in direct sunlight for 6 hours. Participants are expected to drink SODIS treated water for the duration of the study.
Study NCT02673671 — intervention group
Intervention type: DEVICE
Intervention: G-Tech Myoelectric recording device
Description: A minimum of three patches are placed on the abdomen of the patient to record myoelectric activity.
Study NCT00288171 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: placebo capsule twice daily for one month
Study NCT00288171 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Allopurinol
Description: Allopurinol 200mg twice daily for one month
Study NCT02883829 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Peer-Based Web-Based Health Information
Description: The intervention will be a brief vignette to present educational content about alcohol use risks for Type 1 Diabetes; framed and delivered from a peer-based source. The content for the intervention will be drawn on existing theories of behavior change, including the concepts of 'consciousness raising', 'self-reevaluation' and 'helping relationships'. The intervention will comprise of PowerPoint slides for final implementation as a narrated video that can be posted to a website for participant viewing.
Study NCT02883829 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Provider-Based Web-Based Health Information
Description: The intervention will be a brief vignette to present educational content about alcohol use risks for Type 1 Diabetes; framed and delivered from a provider-based source. The content for the intervention will be drawn on existing theories of behavior change, including the concepts of 'consciousness raising', 'self-reevaluation' and 'helping relationships'. The intervention will comprise of PowerPoint slides for final implementation as a narrated video that can be posted to a website for participant viewing.
Study NCT01489956 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Immucothel Alone (Part A)
Description: 100 ug at day 0 (priming dose) and day 9(booster dose)
Study NCT01489956 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Immucothel+Montanide (Part A)
Description: 100 ug SQ Immucothel plus Montanide at day 0 (priming dose) and day 9 (booster dose)
Study NCT01489956 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Immucothel Alone or Immucothel+Montanide (Part B)
Description: 50 mg of native KLH on days 0-4 and 10-14 (total of 500 mg). Immunization on days 26 and 35.
Study NCT03801837 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Macadamia Nut
Description: Participants will be provided with the appropriate portion of macadamia nuts \[15% of daily calories or 30-45 grams based on kcal requirement of the individual\]
Study NCT03801837 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Control Diet
Description: Participants will continue with their Habitual Diet during this part of the intervention
Study NCT03559764 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Anti-BCMA CAR T cells
Description: Transparent colorless or slightly yellow liquid
Study NCT01473758 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Roflumilast
Description: 500 µg tablet, od, oral administration in the morning after breakfast
Study NCT01473758 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: tablet, od, oral administration in the morning after breakfast
Study NCT00192127 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: FluMist
Description: A single dose of either bivalent vaccine or placebo mist by intranasal spray on Study Day 0.
Study NCT00192127 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: A single dose of either bivalent vaccine or placebo mist by intranasal spray on Study Day 0
Study NCT06185712 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Nurse-led disease management education
Description: Nurse-led disease management education was applied to the intervention group
Study NCT02611752 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CAM2038
Description: CAM2038 subcutaneous injection
Study NCT03422783 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Standardized tetanic stimulation
Description: The intervention is not a drug, but it is standardized electrical stimulus applied with a muscle relaxation monitor on the forearm of the anesthetized patient. The NoL index is registered in response to this stimulus in an observational manner.~Device: Device PMD200TM offering intraoperative NoL Index
Study NCT03422783 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Catastrophizing score
Description: Pre-operative catastrophizing score is correlated with post-operative pain and opioid consumption
Study NCT03422783 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Nociceptive threshold
Description: Nociceptive threshold for pressure, heat and electrical stimulation are associated with post-operative pain and will be assessed preoperatively to see if there is correlation between them and the NOL index response to the nociceptive stimulus (see intervention 1)
Study NCT03422783 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Biomarkers
Description: Some biomarkers of inflammation and endogenous opioids are associated with post-operative pain. Blood samples will be withdrawn at D0 before surgery starts, D1 (H24) and D2 (H48) after surgery to see if they correlate with NOL changes after the stimulus described in intervention 1 above
Study NCT01880710 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Subtotal hysterectomy
Description: Subtotal abdominal hysterectomy where the body of the uterus is removed but the cervix is spared.
Study NCT01880710 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Total Hysterectomy
Description: total abdominal hysterectomy where the body as well as the cervix of the uterus are removed.
Study NCT03770871 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Indirect pulp treatment using Dycal (TM)
Description: Partial caries removal and protection of the dental pulp with biocompatible material
Study NCT03770871 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Indirect pulp treatment using Dycal (TM)
Description: Partial caries removal and protection of the dental pulp with biocompatible material
Study NCT03770871 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Indirect pulp treatment using Vitrebond (TM )
Description: Partial caries removal and protection of the dental pulp with biocompatible material
Study NCT03770871 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Indirect pulp treatment using Vitrebond (TM )
Description: Partial caries removal and protection of the dental pulp with biocompatible material
Study NCT01264211 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Diacerein
Description: Week 0 to Week 4: Diacerein 50 mg daily for 4 weeks Week 4 to Week 24: Diacerein 100 mg daily for 20 weeks
Study NCT01264211 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Week 0 to Week 4: Diacerein 50 mg daily for 4 weeks Week 4 to Week 24: Diacerein 100 mg daily for 20 weeks
Study NCT01789281 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Everolimus
Description: Everolimus was provided by the investigator in 2.5 mg, 5 mg or 10 mg tablets for daily oral administration. The starting dose of everolimus was the same as the last dose that was given in the parent study. Dose modification thereafter was done at the discretion of the Investigator based upon what is in the subject's best interest.
Study NCT01789281 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sandostatin LAR Depot
Description: Sandostatin LAR Depot was provided by Novartis or by the investigational site considering local regulations. The dose and frequency of Sandostatin LAR Intramuscular injections was the same as the last dose that was given in the parent study.
Study NCT03070210 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: EUS-celiac ganglia block (EUS-CGB)
Description: The intervention technique of EUS-CGB is the realization of EUS-guided celiac block with injection of bupivacaine directly into the ganglia for patients with chronic pancreatitis.
Study NCT03070210 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: EUS-celiac plexus block (EUS-CPB)
Description: In the arm of EUS-CPB, the procedure is going to be performed with the standard EUS-guided celiac plexus block with injection of bupivacaine into the retroperitoneal space.
Study NCT01294592 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dutasteride plus tamsulosin
Description: Take 1 capsule daily
Study NCT01294592 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: tamsulosin
Description: Take 1 capsule daily when escalation criteria met
Study NCT04457908 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: intelligent assessment
Description: intelligent neurological function assessment
Study NCT05494944 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: ThuLEP
Description: Minimal invasive prostate intervention
Study NCT03401645 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Wrist Alarm
Description: Wrist device with alarm timer
Study NCT03401645 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Home-based Arm and Hand Exercise
Description: Repeated visuomotor tasks, unilateral arm and hand movements, bilateral arm and hand movements
Study NCT03401645 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Home-based Arm and Hand Exercise
Description: Repeated visuomotor tasks, unilateral arm and hand movements, bilateral arm and hand movements
Study NCT00461630 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ER niacin/laropiprant
Study NCT00461630 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: simvastatin
Description: 40 mg simvastatin tablet orally per day as background LDL-lowering treatment allocated at entry based on previous statin treatment and total cholesterol level
Study NCT00461630 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: simvastatin
Description: 40 mg simvastatin tablet orally per day as background LDL-lowering treatment allocated at entry based on previous statin treatment and total cholesterol level
Study NCT00461630 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ezetimibe/simvastatin
Description: 10 mg ezetimibe plus 40 mg simvastatin in single tablet taken once daily as background LDL-lowering treatment allocated at entry based on previous statin treatment and total cholesterol level
Study NCT00461630 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ezetimibe/simvastatin
Description: 10 mg ezetimibe plus 40 mg simvastatin in single tablet taken once daily as background LDL-lowering treatment allocated at entry based on previous statin treatment and total cholesterol level
Study NCT02338323 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Febuxostat
Description: It acts as an inhibitor of xanthine oxidase, thus lowering urate concentrations in the body
Study NCT02097108 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Raltegravir
Study NCT01475136 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY2140023
Study NCT02032420 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: STAR
Study NCT02032420 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: ART
Study NCT02351388 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Transcranial Direct Current Stimulation
Study NCT02351388 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham Stimulation
Study NCT02511808 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Brief Advice
Description: Brief Advice (BA) consists of a 20-minute session delivered by a study therapist, adhering to the NIAAA's Clinician Guide to Problem Drinkers. It includes personalized, normative feedback based on NIAAA drinking norms, goal selection, instructions on self-monitoring, discussion of drink reduction strategies, and distribution of the NIAAA bibliotherapy guide.
Study NCT02511808 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Motivational Interviewing
Description: Motivational Interviewing will consist of standard techniques, such as developing discrepancy, enhancing motivation, and developing a change plan, that have been adapted to treatment for problem drinkers.
Study NCT02511808 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Motivational Interviewing
Description: Motivational Interviewing will consist of standard techniques, such as developing discrepancy, enhancing motivation, and developing a change plan, that have been adapted to treatment for problem drinkers.
Study NCT02511808 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Behavioral Self-Control Training
Description: Behavioral Self-Control Training will consist of Cognitive Behavioral Therapy adapted to problem drinkers, whose core components include a functional analysis, skills training, daily self-monitoring, homework, and graded exposures and mastery of high risk situations.
Study NCT01670747 — intervention group
Intervention type: RADIATION
Intervention: Chest computed tomography
Study NCT02578628 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Patient Engagement
Description: The patient engagement system monitors routine clinical laboratory test results and sends messages to patients and providers when action is indicated, such as when tests are overdue or results require extra clinical attention. Patients receive first class letters directing them to call their provider. Providers receive fax or electronic messages directing them to reach out to the patient to arrange follow-up care.
Study NCT04389944 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: convalescent plasma application to SARS-CoV-2 infected patients
Description: In addition to standard of care, SARS-CoV-2 infected patients for whom blood group compatible convalescent plasma is available and who are willing to sign the informed consent receive convalescent plasma as follows: 200ml at enrolment and 200ml at 12-24 hours follow-up.